19th week of 2018 patent applcation highlights part 10 |
Patent application number | Title | Published |
20180125890 | T CELL WHICH EXPRESSES A GAMMA-DELTA T CELL RECEPTOR (TCR) AND A CHIMERIC ANTIGEN RECEPTOR (CAR) | 2018-05-10 |
20180125891 | Methods of Treating Epstein-Barr Virus-Associated Lymphoproliferative Disorders by T Cell Therapy | 2018-05-10 |
20180125892 | TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS | 2018-05-10 |
20180125893 | PURE PLATELET-RICH PLASMA (P-PRP) COMPOSITION FOR TREATMENT OF SUBCLINICAL MASTITIS AND METHODS OF PRODUCING AND USING THE SAME | 2018-05-10 |
20180125894 | Closed System Separation of Adherent Bone Marrow Stem Cells for Regenerative Medicine Applications | 2018-05-10 |
20180125895 | CARDIAC STEM CELLS FOR CARDIAC REPAIR | 2018-05-10 |
20180125896 | Compositions and Methods for Treatment of Cardiovascular Disorders | 2018-05-10 |
20180125897 | Decellularized Adipose Cell Growth Scaffold | 2018-05-10 |
20180125898 | MARINE LECITHIN PREPARATIONS WITH ENHANCED OXIDATION RESISTANCE | 2018-05-10 |
20180125899 | Methods for Treating Ulcerative Colitis | 2018-05-10 |
20180125900 | PROBIOTIC COMPOSITIONS FOR IMPROVING METABOLISM AND IMMUNITY | 2018-05-10 |
20180125901 | COMPOSITION FOR PREVENTING OR TREATING BONE DISEASE, OBESITY AND LIPID-RELATED METABOLIC DISEASE | 2018-05-10 |
20180125902 | USE OF ANTIBIOTICS WITH SPECIFIC THERAPEUTIC ACTIVITIES COMBINED WITH THE SIMULTANEOUS USE OF LACTOBACILLI AND/OR BIFIDOBACTERIA WITH A NON-TRANSFERABLE ANTIBIOTIC RESISTANCE, HAVING THE SAME THERAPEUTIC INDICATION | 2018-05-10 |
20180125903 | PHARMACEUTICAL COMPOSITION CONTAINING PORTULACA GRANDIFLORA HOOK. EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING NEUROINFLAMMATION OR NEURO-DEGENERATIVE DISEASES | 2018-05-10 |
20180125904 | METHODS AND COMPOSITIONS FOR BONE AND CARTILAGE REPAIR | 2018-05-10 |
20180125905 | PLANT EXTRACT FROM LOW-THC CANNABIS FOR THE TREATMENT OF DISEASE | 2018-05-10 |
20180125906 | CARBOHYDRATE COMPOSITION EXTRACTED FROM PANAX GINSENG AND ITS USE IN THE TREATMENT OF ISCHEMIC CONDITIONS | 2018-05-10 |
20180125907 | NATURAL PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROTIC FRACTURE AND/OR OSTEOARTHRITIS AND USE THEREOF | 2018-05-10 |
20180125908 | METHODS OF TREATING VIRAL INFECTION AND PREPARING ANTIVIRAL COMPOSITIONS | 2018-05-10 |
20180125909 | Composition and method for preventing and treating human dermal reactions | 2018-05-10 |
20180125910 | METHOD OF PRODUCING BEVERAGES ON THE BASIS OF JUICE AND POWDER FROM THE MACA ROOT | 2018-05-10 |
20180125911 | METHOD OF PRODUCING BEVERAGES ON THE BASIS OF JUICE AND POWDER FROM THE MUNG BEAN | 2018-05-10 |
20180125912 | METHOD FOR ENHANCING EFFECT OF IMMUNOTHERAPY FOR CANCER | 2018-05-10 |
20180125913 | ESSENTIAL OIL COMPOSITIONS AND APPLICATIONS UTILIZING ESSENTIAL OILS | 2018-05-10 |
20180125914 | NOVEL COMPOSITION OF NIGELLA SATIVASEEDS TO TREAT ANXIETY, STRESS AND SLEEP DISORDERS WITH SIGNIFICANT MEMORY ENHANCEMENT PROPERTIES AND A PROCESS FOR PRODUCING THE SAME | 2018-05-10 |
20180125915 | NATURAL FORMULATION FOR TREATING HANGOVER | 2018-05-10 |
20180125916 | System and Method for Natural Hair Loss Prevention Oil | 2018-05-10 |
20180125917 | PROCESS OF MAKING WINE FROM A WHOLE GRAPE BUNCH, PROCESS OF MAKING POMACE JUICE AND POWDER, AND METHOD OF PRODUCING BEVERAGES ON THE BASIS OF JUICE AND POWDER FROM A GRAPE BUNCH | 2018-05-10 |
20180125918 | FORMULATIONS FOR THE TREATMENT AND PREVENTION OF OBESITY | 2018-05-10 |
20180125919 | Peptide Treatment for Inflammation and Fibrosis | 2018-05-10 |
20180125920 | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions | 2018-05-10 |
20180125921 | USE OF QBP1 PEPTIDE FOR THE INHIBITION OF MEMORY CONSOLIDATION | 2018-05-10 |
20180125922 | COMPOSITIONS AND METHODS OF USE FOR (PRO)RENIN RECEPTOR ANTAGONISTS | 2018-05-10 |
20180125923 | Therapeutic Peptides For Cerebrovascular Diseases | 2018-05-10 |
20180125924 | SUPRAMOLECULAR GLYCOSAMINOGLYCANS | 2018-05-10 |
20180125925 | NOVEL THERAPEUTICAL TOOLS AND METHODS FOR TREATING BLINDNESS | 2018-05-10 |
20180125926 | Compositions and Formulations and Methods of Production and Use Thereof | 2018-05-10 |
20180125927 | Human Catestatin Induces Gut Microbiota Dysbiosis | 2018-05-10 |
20180125928 | TREATMENT OF BETA-THALASSEMIA USING ACTRII LIGAND TRAPS | 2018-05-10 |
20180125929 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER | 2018-05-10 |
20180125930 | METHODS AND COMPOSITONS FOR METABOLIC REGULATION | 2018-05-10 |
20180125931 | RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS | 2018-05-10 |
20180125932 | MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION | 2018-05-10 |
20180125933 | INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE | 2018-05-10 |
20180125934 | Receptor-Based Antagonists of the Programmed Cell Death 1 (PD-1) Pathway | 2018-05-10 |
20180125935 | COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS | 2018-05-10 |
20180125936 | METHOD OF TREATING NEOPLASIAS | 2018-05-10 |
20180125937 | MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS | 2018-05-10 |
20180125938 | MODIFIED CHEMOKINE PEPTIDE | 2018-05-10 |
20180125939 | NOVEL THERAPY | 2018-05-10 |
20180125940 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ENHANCING TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM | 2018-05-10 |
20180125941 | IL-2 Variants for the Treatment of Autoimmune Diseases | 2018-05-10 |
20180125942 | COMPOSITION FOR TREATMENT OF INFERTILITY | 2018-05-10 |
20180125943 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2018-05-10 |
20180125944 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ASPART | 2018-05-10 |
20180125945 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2018-05-10 |
20180125946 | Treating Diabetes Melitus Using Insulin Injections Administered With Varying Injection Intervals | 2018-05-10 |
20180125947 | TREATMENT OF RETINAL DETACHMENT | 2018-05-10 |
20180125948 | TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS | 2018-05-10 |
20180125949 | Lysosomal Targeting Peptides and Uses Thereof | 2018-05-10 |
20180125950 | LIVER CIRRHOSIS TREATMENT | 2018-05-10 |
20180125951 | METHODS FOR ALLEVIATING HISTAMINE-INDEPENDENT PRURITUS USING NEUROTOXINS | 2018-05-10 |
20180125952 | PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT | 2018-05-10 |
20180125953 | HER2/NEU IMMUNOGENIC COMPOSITION | 2018-05-10 |
20180125954 | VIRUS-LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY | 2018-05-10 |
20180125955 | PLACENTAL VACCINATION THERAPY FOR CANCER | 2018-05-10 |
20180125956 | CRYOPRESERVATION OF APOPTOTIC CANCER CELLS FOR USE IN IMMUNOTHERAPY AGAINST CANCER | 2018-05-10 |
20180125957 | IMMUNOGENIC COMPOSITION COMPRISING MYCOPLASMA ANTIGENS | 2018-05-10 |
20180125958 | Immunogenic Compositions and Uses Thereof | 2018-05-10 |
20180125959 | COMPOSITIONS COMPRISING N. MENINGITIDIS PROTEINS | 2018-05-10 |
20180125960 | MENINGITIDIS VACCINES COMPRISING SUBTILINASES | 2018-05-10 |
20180125961 | NEISSERIA MENINGITIDIS TRYPSIN-LIKE SERINE PROTEASE POLYPEPTIDES AND COMPOSITIONS THEREOF | 2018-05-10 |
20180125962 | Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof | 2018-05-10 |
20180125963 | NON-TYPEABLE HAEMOPHILUS INFLUENZAE VACCINES AND THEIR USES | 2018-05-10 |
20180125964 | CHIMERIC DENGUE VIRUS E GLYCOPROTEINS COMPRISING MUTANT DOMAIN I AND DOMAIN II HINGE REGIONS | 2018-05-10 |
20180125965 | HAND, FOOT, AND MOUTH VACCINES AND METHODS OF MANUFACTURE AND USE THEREOF | 2018-05-10 |
20180125966 | COMPOSITIONS CONTAINING AMBIENT-TEMPERATURE STABLE, INACTIVATED BUT THERAPEUTICALLY ACTIVE BIOPHARMACEUTICALS & METHODS FOR FORMULATION THEREOF | 2018-05-10 |
20180125967 | HIV Immune Stimulating Compositions Comprising Recombinantly Expressed Pili on Bacteria and Methods Related Thereto | 2018-05-10 |
20180125968 | POXVIRAL VACCINES | 2018-05-10 |
20180125969 | METHODS OF RATIONAL NICOTINE HAPTEN DESIGN AND USES THEREOF | 2018-05-10 |
20180125970 | METHODS FOR TREATING LUNG CANCER | 2018-05-10 |
20180125971 | Modulation of the Immune Response | 2018-05-10 |
20180125972 | MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITION, METHOD FOR IDENTIFYING LINEAR EPITOPE, AND METHOD FOR PREPARING MULTIPLE ANTIGEN BINDING MOLECULAR FUSION | 2018-05-10 |
20180125973 | THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD73 ANTIBODIES AND USES THEREOF | 2018-05-10 |
20180125974 | METHODS AND COMPOSITIONS FOR ENHANCED IMMUNOLOGICAL THERAPY AND TARGETING OF GRAM-POSITIVE BACTERIA | 2018-05-10 |
20180125975 | EMISSIVE POLYMERIC MATRICES | 2018-05-10 |
20180125976 | Conjugated Porphyrin Carbon Quantum Dots for Targeted Photodynamic Therapy | 2018-05-10 |
20180125977 | ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS | 2018-05-10 |
20180125978 | Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions | 2018-05-10 |
20180125979 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS | 2018-05-10 |
20180125980 | CANNABINOID COMPOSITION AND PRODUCTS INCLUDING ALPHA-TOCOPHEROL | 2018-05-10 |
20180125981 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2018-05-10 |
20180125982 | Etanercept Formulations Stabilized with Metal Ions | 2018-05-10 |
20180125983 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | 2018-05-10 |
20180125984 | DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF | 2018-05-10 |
20180125985 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | 2018-05-10 |
20180125986 | Nitric Oxide Releasing Produgs of Therapeutic Agents | 2018-05-10 |
20180125987 | COMPOSITIONS FOR TREATING CANCER AND METHODS FOR MAKING THE SAME | 2018-05-10 |
20180125988 | TARGETED XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | 2018-05-10 |
20180125989 | ICE-BASED LIPID NANOPARTICLE FORMULATION FOR DELIVERY OF MRNA | 2018-05-10 |